Meningococcal Disease in Catalonia 1 Year after Mass Vaccination Campaign with Meningococcal Group C Polysaccharide Vaccine

Infection

Volumn 31, Issue 6, 2003, Pages 392-397

  Cardenosa N ^a   Dominguez A ^a   Martinez A ^a   Alvarez, J ^b   Panella H ^c,g   Godoy, P ^d   Minguell, S ^e   Camps, N ^f   Vazquez J A ^g   Carmona, G ^g   Ciruela, P ^g   Garrido, P ^g   Domingo, P ^g   Sanchez F ^g   Fontanals, D ^g   Retana, A ^g   Follia, N ^g   Casellas, C ^g   Pique M ^g   Roure, M C ^g   Batlle, J ^g   Artigues, A ^g   Manonelles, A ^g   Nogues A ^g   Mirada, G ^g   Bach, P ^g   Vallmanya, T ^g   Escatllar, N ^g   Allue J ^g   Santamaria J M ^g   Olona, M ^g   Rebull, J ^g   Perez M M ^g   Escribano, J S ^g   Ballester, F ^g   Maldonado, R ^g   Planas, C ^g   Admella, T ^g   Verdaguer, R ^g   Boronat, M ^g   Xercavins, M ^g   Dougan, M ^g   Orcau, A ^g   Barahona, M ^g   Botia, A M ^g   Cabello, M S ^g   Rodrigo, C ^g   Roca, J ^g   Matilla, P ^g   Escofet, A M ^g   Vila, C ^g   Sitges, J ^g   Cuquet, J ^g   De La Fuente, L ^g   Prats, G ^g   more..

^a GENERALITAT DE CATALUNYA   (Spain)

^b Territorial Delegation of Health   (Spain)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

^d Territorial Delegation of Health   (Spain)

^e Territorial Delegation of Health   (Spain)

^f Territorial Delegation of Health   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; EPIDEMIC MENINGITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MENINGITIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; SCHOOL CHILD; SPAIN;

EID: 10744224263     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3121-6     Document Type: Article

References (39)

1. Dirección Xeral de Saúde Pública: A enfermidade meningocócica en Galicia: tempada 1995/96. Bol Epidemiol Galicia 1996; 9: 1-2.
2. Departement de Sanitat i Seguretat Social: Programa per a la vacunació antimeningocòccica C conjugada a Catalunya. Barcelona: Generalitat de Catalunya, 2000.
3. Berrón S, Vázquez JA: Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship? Clin Infect Dis 1994; 18: 161-165.
4. Burgoa M, Asensio O, García C, et al.: Vigilancia de la enfermedad meningocócica. Bol Epidemiol Sem 1996; 4: 97-100.
5. Salleras L, Domínguez A, Prats G: Control of serogroup C meningococcal disease by mass vaccination in Catalonia (Spain). Vaccine 1999; 17: S56-S60.
6. Fernández S, Arreaza L, Santiago I, et al.: Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect 1999; 123: 349-357.
7. Generalitat de Catalunya: Definició de cas de les malalties de declaració obligatoria. Barcelona: Departament de Sanitat l Seguretat Social, 1997.
8. Institut d'Estadística de Catalunya: Estadistica de població 1996. Barcelona: Institut d'Estadística de Catalunya, 1997.
9. Peltola H: Meningococcal disease: still with us. Rev Infect Dis 1983; 5: 71-91.
10. Fogarty J, Keane CT, Carroll R, et al.: Meningococcal disease in childhood - a regional study in Ireland. J Infect 1994; 28: 199-207.
11. Jones DM, Kaczmarski EB: Meningococcal infections in England and Wales: 1995. Commun Dis Rep CDR Rev 1995; 5: R125-R139.
12. Jackson LA, Wenger JD: Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR Morb Mortal Wkly Rep 1993; 42: 21-30.
13. Connolly M, Noah N: Surveillance of bacterial meningitis in Europe 1994. London: King's European Meningitis Surveillance Unit, 1995.
14. Kaczmarski EB: Meningococcal disease in England and Wales: 1995. Commun Dis Rep CDR Rev 1997; 7: R55-R59.
15. Fogarty J, Cafferkey MT, Moloney AC: Meningococcal disease in the Republic of Ireland: 1995. Commun Dis Rep CDR Rev 1997; 1: R9-R13.
16. Pinner RW, Gellin BG, Bibb WF, et al.: Meningococcal disease in the United States - 1986. J Infect Dis 1991; 164: 368-374.
17. Tikhomirov E, Santamaria M, Esteves K: Meningococcal disease: public health burden and control. World Health Stat Q 1997; 50: 170-177.
18. World Health Organization & Fondation Marcel Mérieux: WHO practical guidelines: control of epidemic meningococcal disease. Lyon: Fondation Marcel Mérieux, 1995.
19. Ramsay M, Kaczmarski E, Rush M, et al.: Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997; 7: R49-R54.
20. Barquet N, Domingo P, Caylà JA, et al.: Prognostic factors in meningococcal disease. JAMA 1997; 278: 491-496.
21. Cizman M, Gubina M, Paragi M, et al.: Meningococcal disease in Slovenia (1993-1999): serogroups and susceptibility to antibiotics. Slovenian Meningitis Study Group. Int J Antimicrob Agents 2001; 17: 27-31.
22. Robles SY, Marrett LD, Clarke AE, et al.: An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 1988; 41: 496-501.
23. Sutter RW, Cochi SL, Brink EW, et al.: Assessment of vital statistics and surveillance data for monitoring tetanus mortality. United States, 1979-1984. Am J Epidemiol 1990; 131: 132-142.
24. Hubert B, Desenclos JC: Evaluation of the exhaustiveness and representativeness of a surveillance system using the capture-recapture method. Application to the surveillance of meningococcal infections in France in 1989 and 1990. Rev Epidemiol Sante Publique 1993; 41: 241-249.
25. Ackman DM, Birkhead G, Flynn M: Assessment of surveillance for meningococcal disease in New York State, 1991. Am J Epidemiol 1996; 144: 78-82.
26. Riordan FA, Thomson AP, Sills JA, et al.: Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ 1996; 313: 1255-1256.
27. Cartwright KAV, Ala'Aldeen DAA: Neisseria meningitidis: clinical aspects. J Infect 1997; 34: 15-19.
28. Ward J, Hanna JN, Bates JR, et al.: Enhanced surveillance for meningococcal disease in Queensland in 1999. Commun Dis Intell 2000; 24: 332-335.
29. Wylie PAL, Stevens D, Drake W III, et al.: Epidemiology and clinical management of meningococcal disease in west Gloucestershire: retrospective, population based study. BMJ 1997; 315: 774-779.
30. Hawker JI, Olowokure B, Parr L: Enhanced surveillance of meningococcal disease in the West Midlands: 1996 to 1998. Commun Dis Public Health 1999; 2: 269-272.
31. Davies LA: Assessing the value of different sources of information on meningococcal disease. Commun Med 1989; II: 239-246.
32. Carrol ED, Thomson AP, Riordan FA, et al.: Increasing microbiological confirmation and changing epidemiology of meningococcal disease on Merseyside, England. Clin Microbiol Infect 2000; 6: 259-262.
33. Krizova P, Musilek M: Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone N. meningitidis C:2a:P1.2(P1.5), ET-15/37. Cent Eur J Public Health 1995; 3: 189-194.
34. Hubert B, Caugant DA: Recent changes in meningococcal disease in Europe. EuroSurveillance 1997; 2: 69-71.
35. Connolly M, Noah N: Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect 1999; 122: 41-49.
36. Jackson LA, Schuchat A, Reeves MW, et al.: Serogroup C meningococcal outbreaks In the United States. An emerging threat. JAMA 1995; 273: 383-389.
37. Pastor P, Medley FB, Murphy TV: Meningococcal disease in Dallas County, Texas: results of a six-year population-based study. Pediatr Infect Dis J 2000; 19: 324-328.
38. Cano Portero R, García Delgado C, de Mateo Ontañón S: Meningococcal disease. The situation in Spain in the 1998-1999 period. Rev Esp Salud Publica 2000; 74: 369-375.
39. Alcalá B, Arreaza L, Salcedo C, et al.: Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains alter mass immunization campaign, Spain. Emerg Infect Dis 2002; 8: 1512-1514.